Global Pharmacovigilance Market Size, Share, Trends, and Forecast 2026-2030 | AI, Cloud-Based Platforms, and Outsourcing Drive USD 3.37 Billion Growth at 6.1% CAGR
Dublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- "Global Pharmacovigilance Market 2026-2030" has been added to ResearchAndMarkets.com's offering.
Global Pharmacovigilance Market to Grow by USD 3.37 Billion from 2025-2030
The global pharmacovigilance market is forecast to increase by USD 3.37 billion between 2025-2030, expanding at a CAGR of 6.1% during the forecast period. According to the report, market growth is being supported by the rising global burden of chronic diseases, increasing polypharmacy, stricter regulatory frameworks, international harmonization initiatives and the rapid adoption of automated safety data management technologies.
The report provides an up-to-date assessment of the global pharmacovigilance market, including market size, forecasts, industry trends, growth drivers, operational challenges and competitive analysis. It also evaluates approximately 25 vendors, offering insights designed to help organizations assess market positioning and identify emerging commercial opportunities.
Artificial intelligence and machine learning integration in signal detection is expected to be a major factor influencing pharmacovigilance market growth. These technologies are improving the processing and analysis of safety data while supporting more efficient identification of potential adverse drug reactions. The market is also benefiting from a broader shift toward active surveillance, real world evidence integration and advanced electronic health record analysis.
Demand for contract outsourcing and functional service provider models is projected to rise as pharmaceutical, biotechnology and medical device companies seek scalable access to specialized safety expertise. Outsourcing can help organizations manage growing case volumes, comply with regional requirements and improve operational efficiency across drug safety activities. At the same time, in-house pharmacovigilance remains important for companies seeking direct control over safety operations, data governance and regulatory compliance.
Market segmentation by service:
Market segmentation by deployment:
Cloud-based deployment is gaining attention as companies prioritize scalability, centralized access and streamlined safety data management. On-premises systems continue to serve organizations with specific infrastructure, security or compliance requirements, while hybrid deployment models provide flexibility by combining both environments.
Market segmentation by type:
Geographic coverage:
The regional analysis examines market conditions and growth opportunities across major countries and territories. Regulatory developments, healthcare infrastructure, clinical research activity, technology adoption and pharmaceutical industry investment are among the factors shaping demand in each geography.
The competitive landscape includes AB Cube SARL, Allucent, APCER Life Sciences Inc., ArisGlobal LLC, ClinChoice Inc., Ennov SAS, Eversana Life Science Services LLC, EXTEDO GmbH, Fortrea Holdings Inc, Freyr Software Services, ICON plc, IQVIA Holdings Inc., MakroCare, Medpace Holdings Inc., Navitas Life Sciences, Parexel International Corp., ProPharma Group Holdings LLC, Syneos Health Inc., Veristat LLC and Worldwide Clinical Trials Holdings.
The vendor analysis reviews key companies and market dynamics to support strategic planning, competitive benchmarking and vendor selection. It considers factors such as pricing, profitability, competition, promotional activity and the influence of major industry participants. The report also identifies upcoming trends and challenges that may affect market performance, enabling companies to evaluate risks and pursue future growth opportunities.
The findings are based on a combination of primary and secondary research, including input from key industry participants. Historical and forecast data, qualitative assessments and quantitative analysis have been synthesized to provide a comprehensive view of the global pharmacovigilance market. The report covers market sizing, market forecasts, segment performance, regional developments and the evolving vendor landscape.
Key Topics Covered:
1 Executive Summary
1.1 Market overview
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges
3 Market Landscape
3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
4.2 Market segment analysis
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
5.1 Global Pharmacovigilance Market 2020 - 2024
5.2 Service segment analysis 2020 - 2024
5.3 Deployment segment analysis 2020 - 2024
5.4 Type segment analysis 2020 - 2024
5.5 Geography segment analysis 2020 - 2024
5.6 Country segment analysis 2020 - 2024
6 Qualitative Analysis
6.1 Impact of AI on Global Pharmacovigilance Market
6.2 Impact of Geopolitical Conflicts on Global Pharmacovigilance Market
7 Five Forces Analysis
7.1 Five forces summary
7.2 Bargaining power of buyers
7.3 Bargaining power of suppliers
7.4 Threat of new entrants
7.5 Threat of substitutes
7.6 Threat of rivalry
7.7 Market condition
8 Market Segmentation by Service
8.1 Market segments
8.2 Comparison by Service
8.3 In-house - Market size and forecast 2025-2030
8.4 Contract outsourcing - Market size and forecast 2025-2030
8.5 Market opportunity by Service
9 Market Segmentation by Deployment
9.1 Market segments
9.2 Comparison by Deployment
9.3 Cloud-based - Market size and forecast 2025-2030
9.4 On-premises - Market size and forecast 2025-2030
9.5 Hybrid - Market size and forecast 2025-2030
9.6 Market opportunity by Deployment
10 Market Segmentation by Type
10.1 Market segments
10.2 Comparison by Type
10.3 Spontaneous reporting - Market size and forecast 2025-2030
10.4 Cohort event monitoring - Market size and forecast 2025-2030
10.5 Intensified ADR reporting - Market size and forecast 2025-2030
10.6 Targeted spontaneous reporting - Market size and forecast 2025-2030
10.7 EHR mining - Market size and forecast 2025-2030
10.8 Market opportunity by Type
11 Customer Landscape
11.1 Customer landscape overview
12 Geographic Landscape
12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
12.3.1 US - Market size and forecast 2025-2030
12.3.2 Canada - Market size and forecast 2025-2030
12.3.3 Mexico - Market size and forecast 2025-2030
12.4 Europe - Market size and forecast 2025-2030
12.4.1 Germany - Market size and forecast 2025-2030
12.4.2 UK - Market size and forecast 2025-2030
12.4.3 France - Market size and forecast 2025-2030
12.4.4 Italy - Market size and forecast 2025-2030
12.4.5 Spain - Market size and forecast 2025-2030
12.4.6 The Netherlands - Market size and forecast 2025-2030
12.5 Asia - Market size and forecast 2025-2030
12.5.1 China - Market size and forecast 2025-2030
12.5.2 Japan - Market size and forecast 2025-2030
12.5.3 India - Market size and forecast 2025-2030
12.5.4 South Korea - Market size and forecast 2025-2030
12.5.5 Indonesia - Market size and forecast 2025-2030
12.5.6 Thailand - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
12.6.1 Brazil - Market size and forecast 2025-2030
12.6.2 South Africa - Market size and forecast 2025-2030
12.6.3 Saudi Arabia - Market size and forecast 2025-2030
12.6.4 Turkey - Market size and forecast 2025-2030
12.6.5 Israel - Market size and forecast 2025-2030
12.6.6 UAE - Market size and forecast 2025-2030
12.6.7 Argentina - Market size and forecast 2025-2030
12.6.8 Colombia - Market size and forecast 2025-2030
12.7 Market opportunity by geography
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
13.4 Market opportunities
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.3 Landscape disruption
14.4 Industry risks
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
15.4 AB Cube SARL
15.5 ArisGlobal LLC
15.6 Ennov SAS
15.7 Eversana Life Science Services LLC
15.8 EXTEDO GmbH
15.9 Fortrea Holdings Inc
15.10 ICON plc
15.11 IQVIA Holdings Inc.
15.12 Medpace Holdings Inc.
15.13 Navitas Life Sciences
15.14 Parexel International Corp.
15.15 ProPharma Group Holdings LLC
15.16 Syneos Health Inc.
15.17 Veristat LLC
15.18 Worldwide Clinical Trials Holdings
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
16.3 Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
16.10 List of abbreviations
List of Exhibits [297]
A selection of companies mentioned in this report includes, but is not limited to:
For more information about this report visit https://www.researchandmarkets.com/r/cvmmgg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.